Send the following on WhatsApp
Continue to ChatA phase 2 a, randomized open label study to evaluate the efficacy, safety tolerability, pharmocokinetics and pharmacodynamics of ISIS 702843 Administered subcutaneously to patients with non-transfusion depenmdent B- thalassemia intermedia - https://avesis.istanbul.edu.tr/proje/8cd2efca-ce74-4c64-9845-4c54b7b0a649/a-phase-2-a-randomized-open-label-study-to-evaluate-the-efficacy-safety-tolerability-pharmocokinetics-and-pharmacodynamics-of-isis-702843-administered-subcutaneously-to-patients-with-non-transfusion-depenmdent-b-thalassemia-intermedia